BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Neurotech’s ENCELTO™ (revakinagene taroretcel-lwey) Approved by the FDA for the Treatment of Macular Telangiectasia Type 2 (MacTel)

  March 6, 2025

   · 

  6 min read
• 

  C-suite

  Biotech a Bright Spot for Female Founders Amid DEI Pullback

  A new Pitchbook report found $4.3 billion in funding to women-fronted biotech companies across 121 deals. The increase comes as sociopolitical headwinds slam into initiatives to support women and minorities.

  March 6, 2025

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025

  March 6, 2025

   · 

  1 min read
• Press Releases

  Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark

  March 6, 2025

   · 

  7 min read
• Press Releases

  ImmunoGenesis Doses First Patient in Phase 1/2 Clinical Trial of IMGS-101 in Combination With Balstilimab (anti-PD-1) and Zalifrelimab (anti-CTLA-4) in Relapsed or Refractory Advanced Prostate, Pancreatic, and HPV(-) Head & Neck Tumors

  March 6, 2025

   · 

  4 min read
• Press Releases

  Luxa Biotechnology Presents Clinical Data from First-in-Human Retinal Pigment Epithelium Cell Therapy Trial for Dry Age-Related Macular Degeneration at the 77th Annual Wills Eye Conference

  March 6, 2025

   · 

  4 min read
• Press Releases

  Hemostemix and FireFly Neuroscience’s Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01

  A growing body of clinical evidence supports the use of Firefly’s FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment for vascular dementia

  March 6, 2025

   · 

  10 min read
• Press Releases

  BioHarvest Sciences to Participate in 37th Annual Roth Conference on March 16-18, 2025

  March 6, 2025

   · 

  2 min read
• Press Releases

  Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)

  The Interim Analysis Showed Complete Clinical Clearance of More than Sixty (60%) Percent

  March 6, 2025

   · 

  6 min read
• Press Releases

  Solid Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

  March 6, 2025

   · 

  14 min read